A pharmaceutical company focused on advancement of unmet vaccines against viruses that cause serious human diseases such as respiratory syncytial virus (RSV). Meissa Vaccines applies their platform technology for viral genetic engineering to multiple pathogens.
Meissa was founded by Dr. Martin Moore and Dr. Roderick Tang, a vaccine manufacturing expert. As of 2019 the company was a resident at the Johnson & Johnson InnovationJohnson & Johnson Innovation JLABS in South San Francisco.